Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Greenbaum: Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment.... (0.14 sec) 

Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell …

- nih.gov - Free from Publisher
CJ Greenbaum, T Mandrup-Poulsen, PF McGee, T … - Diabetes care, 2008 - Am Diabetes Assoc
RESULTS—Among individuals with up to 4 years' duration of type 1 diabetes,
>85% had measurable stimulated C-peptide values. The MMTT stimulus produced
significantly higher concentrations of C-peptide than the GST. Whereas both ...
Cited by 6 - Related articles - All 6 versions

[CITATION] Type 1 Diabetes Trial Net Research Group, European C-Peptide Trial Study Group. Mixed meal …


CJ Greenbaum, T Mandrup-Poulsen, PF … - Diabetes Care, 2008
Cited by 3 - Related articles

Adequate doses of autoantigen administered using the appropriate route may create …


J Ludvigsson - Diabetologia, 2009 - Springer
To the Editor: Changes in lifestyle and environment may explain the dramatically
increased incidence of allergic and autoimmune diseases. Although treatment has
become more effective, there are several common autoimmune diseases, such ...
Cited by 1 - Related articles - All 2 versions

The case for intravenous arginine stimulation in lieu of mixed-meal tolerance tests as …


C Greenbaum, K Seidel, C Pihoker - Diabetes care, 2004 - Am Diabetes Assoc
Residual β-cell function in patients with type 1 diabetes has been generally
determined by C-peptide response to stimulation by a liquid mixed-meal tolerance
test (MMTT) or intravenous glucagon (1). Early trials assessed benefits of ...
Cited by 7 - Related articles - BL Direct - All 5 versions

[CITATION] et 31. al. Role of C-peptide in human physiology


J Wahren, K Ekberg, J Johansson - Am J Physiol Endocrinol Metab, 2000
Cited by 2 - Related articles

New potential treatments for protection of pancreatic B-cell function in Type 1 diabetes


S Cernea, P Pozzilli, 2008 - pubmedcentral.nih.gov
Type 1 diabetes mellitus results from the progressive and specific autoimmune
destruction of insulin-secreting pancreatic B-cells, which develops over a
period of years and continues after the initial clinical presentation. The ...
Cited by 2 - Related articles - All 4 versions

GAD65 as a prototypic autoantigen


G Fenalti, MJ Rowley - Journal of Autoimmunity, 2008 - Elsevier
The repertoire of known autoantigens is limited to a very small proportion of
all human proteins, and the reason why only some proteins become autoantigens is
unclear, but is likely associated with structural features. The 65 kDa ...
Cited by 3 - Related articles - All 3 versions

[CITATION] Encyclopedia of Life Sciences


JF Barker, 2004 - John Wiley & Sons
Cited by 2 - Related articles

[PDF] Prospects and challenges for islet regeneration as a treatment for diabetes: A review of …


A Fleming, L Rosenberg - J Diabetes Sci Technol, 2007 - journalofdst.org
Diabetes mellitus results from inadequate insulin action, which can be viewed as
a consequence of the limited ability to restore b cells after they are lost as
the result of metabolic exhaustion, autoimmune destruction, or surgical ...
Cited by 4 - Related articles - View as HTML - All 3 versions

Immunoglobulins in children with autoimmune diabetes mellitus.


E Heinze - Clinical and experimental rheumatology - ncbi.nlm.nih.gov
In this paper we review the results of six studies, published between 1985 and
1993, which report on immunoglobulin treatment in children with idiopathic
diabetes mellitus (IDDM). A total of 77 children with newly diagnosed IDDM ...
Cited by 6 - Related articles - BL Direct - All 2 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google